KLI

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

Metadata Downloads
Publisher
ANNALS OF ONCOLOGY
Language
영어
ISSN
0923-7534
Citation Volume
31
Citation Number
8
Citation Start Page
1030
Citation End Page
1039
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.